Our Team

Our Board of Directors and Scientific Advisors are experts in their fields, bringing track records of innovative thinking across disciplines and valued for their insights into solving some of the most intractable problems in medicine today.

We are well-connected internationally, and in both academic and industry circles.

We have a proven track record of "breaking silos" and cross-disciplinary thinking - so critical for addressing complex diseases and systems.

We are headquartered in Boston, a hub of outstanding science and medical talent, and have strong educational and professional ties to Harvard University, Boston Medical Center and other premier research institutions.

Board of Directors

Vidula Sukhatme,
M.S. (Chair)

Founder & CEO,
GlobalCures, Inc., Newton, MA

Vikas P. Sukhatme,
M.D., Sc.D.

GlobalCures, Inc., Newton, MA

Victor J. Aresty Professor of Medicine, Harvard Medical School

Chief Academic Officer, Beth Israel Deaconess Medical Center, Boston, MA

Rajiv Lal

Stanley Roth, Sr. Professor of Retailing

Harvard Business School, Cambridge, MA

Vidula is co-founder and Chief Executive Officer of GlobalCures. She holds an M.S. in mathematics from Northeastern University and an M.S. from the Harvard School of Public Health in epidemiology. She has 20 years of experience in information systems in a healthcare environment.
Vikas received a Sc.D. in physics from MIT and an M.D. from Harvard Medical School. He is a physician engaged in both basic science and patient-oriented research at Harvard, where he is the Victor J. Aresty Professor of Medicine. He is also the Chief Academic Officer at Beth Israel Deaconess Medical Center, Boston. His primary interest is in cancer research but his research has spanned such diverse areas as toxemia of pregnancy and sepsis.
Rajiv did his undergraduate work in mechanical engineering at the Indian Institute of Technology at Kanpur, India and received his Ph.D. in Industrial Administration from Carnegie-Mellon University. Dr. Lal is the Stanley Roth, Sr. Professor of Retailing at Harvard Business School prior to which Dr. Lal taught at the Graduate School of Business at Stanford University where he had been since 1982. In addition, Dr. Lal was the Thomas Henry Carroll Ford Foundation Visiting Professor at Harvard Business School for 1997-98, and the visiting Professor of Marketing at INSEAD, France in 1986, 1988, 1992 and 1993. Dr. Lal also serves as the co-editor of the journal Quantitative Marketing and Economics and has been an Area Editor for Marketing Science.
Philip graduated from Colby College and Columbia University School of Law. Mr. Chase is the Vice President (Legal) at Alnylum Pharmaceuticals in Cambridge, MA. Prior to this assignment, Mr. Chase served as Vice President and General Counsel of RenaMed Biologics, a biotechnology company, Vice President and General Counsel of EPIX Pharmaceuticals, and Chief Corporate Counsel of Transkaryotic Therapies, Inc. He also worked at the law firms of Skadden, Arps, Slate, Meagher & Flom and Shearman & Sterling. He is an experienced attorney specializing in representing members of the pharmaceutical industry.
Amy received a B.A. from Princeton University and an M.B.A. from the Amos Tuck school of Dartmouth College. Most recently, Ms. Hedison served as Vice President, Investor Relations at EPIX Pharmaceuticals. Prior to joining EPIX, Ms. Hedison served as Director of Investor Relations at EXACT Sciences, a pharmaceutical company, and as Director of Investor Relations and Director of Marketing at Gomez, Inc., an Internet quality measurement firm. Prior to Gomez, Ms. Hedison spent six years at Biogen, Inc. (now Biogen-IDEC), where she held several positions, including Director of Investor Relations. She was also a senior member of the marketing team that launched Biogen's first product, AVONEX(TM). She is an experienced executive in the pharmaceutical industry.
Sharon is currently at Harvard Medical School and has been teaching at Harvard University since 1990, including 5 years as an Instructor at the Harvard Business School. As a Director for Clinical Quality Harvard Medical International, Sharon provided teaching and training to hospitals and health care organizations in 15 countries. Previously Sharon was the Director of Care Improvement at the Brigham and Women's Hospital, an affiliated hospital of Harvard Medical School.

Philip T. Chase II,

General Counsel

Adimab, Lebanon, NH

Amy Seltzer Hedison

Former Head of Investor Relations and Corporate Communications,

EPIX Pharmaceuticals Inc., Cambridge, MA

Sharon Kleefield

Former Director of Clinical Quality,

Harvard Medical International, Boston, MA


Our Collaborating Hospital

Boston Medical Center is a private, not for profit, 581-licensed bed academic medical center located in Boston's historic South End. The hospital is the primary teaching affiliate for Boston University School of Medicine. Emphasizing community-based care, Boston Medical Center with its mission to provide consistently accessible health services to all is the largest safety net hospital in New England.

Our Staff

Kamal Gupta, Ph.D., M.B.A.
Executive Director, GlobalCures

Eugene Brown, Ph.D.
Senior Scientist, GlobalCures

Smita Parikh, M.D.
Medical Director, GlobalCures


Scientific Advisors:

Gauri Bhide, M.D.
Medical Oncologist, Boston, MA

Gauthier Bouche, M.D.
Medical Expert, Anticancer Fund, Belgium

Lydie MeheusPh.D. 
Executive Director, Anticancer Fund, Belgium

Santosh Kesari, M.D.Ph.D. 
Chief, Division of Neuto-Oncology, Associate Professor of Neurosciences, University of California, San Diego, CA

​John D. Halamka, M.D., M.S.
Professor of Medicine, Harvard Medical School, Boston, MA Chief Information Officer, Beth Israel Deaconess Medical Center, Boston, MA

Sanjiv Chopra, M.D.
Faculty Dean for Continuing Education Professor of Medicine, Harvard Medical School, Boston, MA

David Seldin, M.D., Ph.D.
Professor of Medicine and Microbiology, Chief of the Section of Hematology-Oncology, Boston Medical Center, Boston, MA

David Frank, M.D., Ph.D.
Associate Professor of Medicine Harvard Medical School, Dana Farber Cancer Institute, Boston, MA

Patient Advocates:

Robert Brown, M.D.
Beth Israel Deaconess Medical Center Boston, MA

Ben Williams, Ph.D.
San Diego, CA Author of "Surviving Terminal Cancer"